Eldon C. Mayer III - 14 Mar 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc.

Role
Ex VP & Chief Commerc. Officer
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Mar 2022
Net transactions value
-$9,275
Form type
4
Filing time
14 Mar 2022, 21:21:35 UTC
Previous filing
11 Mar 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Sale $9,275 -1,657 -2.7% $5.60 60,468 14 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person in a pre-elected sell-to-cover transaction to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 14, 2022 for 3,959 shares.